Weight Watchers (WW) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
15 May, 2026Executive summary
Settlement agreement reached with former President and CEO Tara Comonte following her resignation effective March 31, 2026, including cash payments and legal fee coverage.
Forward-looking statements caution about risks and uncertainties that may affect future results, referencing recent SEC filings for detailed risk factors.
Board of directors and corporate governance
CEO transition formalized with the resignation of Tara Comonte and execution of a settlement agreement.
Executive compensation and say-on-pay
Settlement includes $1,850,000 in cash payments to be made in two installments and $150,000 for legal fees to Ms. Comonte's counsel.
Settlement agreement contains mutual release of claims, non-disparagement, and confidentiality covenants.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Weight Watchers
- Q2 2026 saw revenue fall 14% but strong Clinical growth and reaffirmed guidance.WW
Q2 2026 - Board urges support for director nominees and revamped executive compensation post-bankruptcy.WW
Proxy filing - Clinical growth and strong margins offset net loss; 2026 guidance and debt reduction reaffirmed.WW
Q1 2026 - Shareholders will vote on directors, auditor, and executive pay after a transformative restructuring.WW
Proxy filing - Clinical subscriber growth and higher ARPU drive 2026 outlook despite behavioral headwinds.WW
Q4 2025 - GLP-1 integration, financial restructuring, and targeted programs drive innovation and growth.WW
CJS Securities 26th Annual "New Ideas for the New Year” Investor Conference - Q3 revenue and subscribers fell, but clinical growth and cost actions supported margin gains.WW
Q3 2024 - Q2 2024 revenue fell 10.9% as clinical subscribers surged 120% and cost savings were targeted.WW
Q2 2024 - Clinical growth and cost cuts offset declines, but bankruptcy and high debt loom.WW
Q1 2025